Roche Makes $750M Bet on AI with Acquisition of Pathology Specialist PathAI
Swiss pharmaceutical giant Roche is significantly expanding its footprint in digital pathology with the acquisition of US-based AI firm PathAI. The deal aims to merge Roche's diagnostic expertise with AI-powered systems to accelerate drug development and advance personalized medicine.



